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Abstract: The objective of this study was to investigate the use of cationized Pleurotus 
eryngii polysaccharide (CPEPS) as a nonviral gene delivery vehicle to transfer plasmid DNA 
  encoding transforming growth factor beta-1 (pTGF-β1) into mesenchymal stem cells (MSCs) 
in vitro. Crude P . eryngii polysaccharide was purified, and then cationized by grafting sper-
mine onto the backbone of the polysaccharide. Agarose gel electrophoresis, transmission 
electron microscopy, and a Nano Sense Zetasizer (Malvern Instruments, Malvern, UK) were 
used to characterize the CPEPS-pTGF-β1 nanoparticles. The findings of cytotoxicity analysis 
showed that when the nanoparticles were formulated with a CPEPS/pTGF-β1 weight ratio 
$ 10:1, a greater gel retardation effect was observed during agarose gel electrophoresis. The 
CPEPS-pTGF-β1 nanoparticles with a weight ratio of 20:1, respectively, possessed an average 
particle size of 80.8 nm in diameter and a zeta potential of +17.4 ± 0.1 mV . Significantly, these 
CPEPS-pTGF-β1 nanoparticles showed lower cytotoxicity and higher transfection efficiency 
than both polyethylenimine (25 kDa) (P = 0.006, Student’s t-test) and LipofectamineTM 2000 
(P = 0.002, Student’s t-test). Additionally, the messenger RNA expression level of TGF-β1 in 
MSCs transfected with CPEPS-pTGF-β1 nanoparticles was significantly higher than that of 
free plasmid DNA-transfected MSCs and slightly elevated compared with that of Lipofectamine 
2000-transfected MSCs. Flow cytometry analysis demonstrated that 92.38% of MSCs were 
arrested in the G1 phase after being transfected with CPEPS-pTGF-β1 nanoparticles, indicat-
ing a tendency toward differentiation. In summary, the findings of this study suggest that the 
CPEPS-pTGF-β1 nanoparticles prepared in this work exhibited excellent transfection efficiency 
and low toxicity. Therefore, they could be developed into a promising nonviral vector for gene 
delivery in vitro.
Keywords: nonviral gene vector, transfection, plasmid DNA, spermine
Introduction
Gene therapy has been well defined as a strategy for transferring nucleic acids, such 
as therapeutic DNA, antisense oligonucleotides, and small interfering RNA, to the 
target tissues or cells to correct or supplement the defective genes that are responsible 
for disease development.1–4 The ideal gene delivery system must be able to protect the 
nucleic acid from many types of degrading systems such as DNA-degrading enzymes 
and lysosomes,5 in order to penetrate the cell membrane and gain entry into the target 
cells, and to promote efficient gene expression. The system must also possess specific 
properties including biocompatibility, biodegradability, nontoxicity, nonimmunogenic-
ity, and stability, during storage and treatment.1,6 However, the lack of safe and efficient 
vectors for DNA delivery is currently a major hurdle for the success of gene therapy. 
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Gene delivery systems can be classified into viral and non-
viral systems.7 Despite the fact that viral gene carriers are 
widely employed in clinical treatments due to their high trans-
fection efficiency and long-term gene expression,8,9 there are 
several limitations that impede their applications, including 
immunogenic properties and the potential to cause mutational 
infection and toxic side effects.10 Nonviral gene vectors have 
emerged as a promising alternative to viral vectors because 
they offer such advantages as low immunogenicity, increased 
biological safety, the ability to deliver large genes, excellent 
flexibility in their building block structures, and the possibil-
ity of large-scale production at a reasonable cost.11,12
As the leading nonviral gene vectors, cationic polymers 
can form complexes with the negatively charged nucleic acids 
so that large pieces of these nucleic acids can be condensed 
to nanometer-sized particles. This promotes the interac-
tion of cationic polymers with the negatively charged cell 
membrane, which protects the incorporated nucleic acids 
in the complex from many types of degrading systems.13,14 
A large number of cationic polymers have been designed 
as gene carriers, such as cationized gelatin,15 poly(l-lysine) 
(PLL) polymers,16–18 polyethylenimine (PEI),19–21 and so on. 
However, these polymers suffer several inherent disadvan-
tages including high toxicity, poor biodegradability, and low 
transfection efficiency.
In recent years, cationic polysaccharide, a type of natural, 
water-soluble, nontoxic, biocompatible and biodegradable 
cationic polymer, has been receiving increasing scientific 
attention and is considered to be the most attractive candidate 
for gene transfer.22 Compared with other cationic polymers, 
cationic polysaccharide presents such advantages as the pres-
ence of groups that can be easily modified to improve the 
physicochemical properties and cellular uptake, which can be 
facilitated by a sugar-recognition receptor on the cell surface.23 
Chitosan, a naturally occurring linear amino polysaccharide, 
has been reported as a vector for gene delivery.24 Researchers 
have found that apart from its biocompatibility, biodegrad-
ability, and low toxicity, chitosan and its derivatives showed 
excellent ability to transfer genes into cells.25–27   However, 
chitosan has demonstrated lower transfection efficiency 
compared with conventional nonviral gene carriers such as 
liposomes,28 PEI,29 and LipofectamineTM 2000 (Invitrogen, 
Carlsbad, CA).30 Other leading cationic   polysaccharides that 
have been investigated as gene vectors include dextran,7,31–33 
pullulan,34,35 pectin,36 and schizophyllan.22,37
The cationization of polysaccharide is a promising 
strategy to develop nonviral gene vectors for use in gene 
therapy.38,39 Polysaccharides represent a structurally diverse 
class of macromolecules of widespread occurrence in 
nature and offer a high capacity for carrying biological 
information because they have great potential for structural 
variability.40 In support of the above findings, the aim of 
this study was to develop a nonviral gene vector by graft-
ing spermine residues onto a polysaccharide extracted 
from Pleurotus eryngii. P . eryngii is an edible mushroom 
which is very common in China. Mushrooms are known 
for their nutritional and medicinal values as well as for 
the diversity of their bioactive components such as nucle-
ases,41 proteases,42 and polysaccharides.43,44 They also con-
tain polysaccharide–peptide and polysaccharide–protein 
  complexes.45 So far, most of the research regarding P . eryngii 
has focused on its enzymes.46–48 One of the major compo-
nents of P . eryngii, the polysaccharide of P . eryngii (PEPS), 
has been studied because of its positive health effects, which 
include cholesterol-lowering, antioxidant, and anticancer 
activities; however, little investigation into its application 
as a gene vector has been carried out.49 Previous stud-
ies have indicated that the polysaccharides isolated from 
P . eryngii were mostly β-glucans, which exhibited potential 
prebiotic activities.50 Therefore, to construct a cationic 
polysaccharide for use as a gene carrier, this study chemi-
cally modified PEPS by the reductive amination method. 
Cationized PEPS (CPEPS) enjoys the merits of both the 
positive charge of amine compounds and the bioactivity of 
PEPS. This advantage is favorable for delivering plasmid 
DNA into cells in vitro.
Nanoparticles are a desirable vehicle for gene delivery 
because of their nanoscale particle size, good stability, and 
excellent diffusion properties, which may facilitate cellular 
uptake.51,52 The plasmid encoding transforming growth 
factor beta-1 (TGF-β1) was used in the study. TGF-β1 is a 
widely used cytokine which can participate in and regulate 
many kinds of biochemical processes, including cell growth 
and differentiation, the formation of extracellular matrices, 
cytoadherence, immunoregulation, embryonic development, 
and wound healing.53,54 It has been reported that TGF-β1 
was able to induce mesenchymal stem cells (MSCs) to dif-
ferentiate into chondrocytes in three-dimensional scaffolds, 
and this study is exactly aimed at this direction. Therefore, 
plasmid TGF-β1 (pTGF-β1)was combined with CPEPS, 
resulting in CPEPS-p TGF-β1 nanoparticles that would have 
the ability to condense large plasmid DNA into nanoscaled 
supermolecular assemblies. The driving force for the compl-
exation comes from the attraction between the two oppositely 
charged ions of each polyelectrolyte. Such properties as 
particle size distribution, zeta potential, and gel retardation 
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effect were rigorously tested to characterize the CPEPS. 
Most importantly, the in vitro transfection efficiency of the 
CPEPS/plasmid DNA nanoparticles was investigated, and 
cytotoxicity was also tested by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) method.55 
It is expected that CPEPS could be developed into a promis-
ing nonviral gene vector for gene therapy.
Materials and methods
Materials
P . eryngii were kindly provided by the Zhenjiang edible 
mushroom growth base (Zhenjiang, China). Spermine and 
branched PEI (molecular weight 25 kDa) were purchased 
from Sigma-Aldrich (St Louis, MO). Dulbecco’s modified 
Eagle’s medium (DMEM), penicillin–streptomycin, trypsin, 
MTT, fetal bovine serum (FBS), and Lipofectamine 2000 
were obtained from Invitrogen (Carlsbad, CA). All other 
chemicals and reagents were of analytical or even higher 
grade and were used without further purification. All solu-
tions were prepared with double distilled water (DDW). 
The experimental protocol was approved by the University 
Ethics Committee for the use of experimental animals and 
conformed to the Guide for the Care and Use of Laboratory 
Animals.56
Polysaccharide extraction and purification
The polysaccharide was extracted from the fruiting bodies of 
P . eryngii by purification, as illustrated in Figure 1. The milled 
fruiting bodies of P . eryngii (2000 g) were extracted with 2 L of 
distilled water at 90°C for 3 hours (repeated three times). The 
aqueous extracts were concentrated under reduced pressure at 
50°C and precipitated with absolute ethanol (with a final etha-
nol concentration of 75% (v/v)). The precipitate was washed 
twice with absolute ethyl alcohol, and further dissolved in 
distilled water. This was dialyzed for 48 hours against dis-
tilled water (molecular weight cutoff [MWCO] 8000–14,400, 
Biosharp).39 The retentate portion was centrifuged to remove 
insoluble material. The supernatant was lyophilized, and then 
primrose-yellow crude PEPS was obtained.
The crude PEPS was purified by anion–exchange chro-
matography on a column (D 2.6 cm × 40 cm, Shanghai Huxi 
Analysis Instrument Factory Co, Ltd, China) filled with 
DEAE-52 cellulose resin (Whatman, UK). Then, the fractions 
that were collected from the DEAE-52 cellulose resin chro-
matographic column were loaded onto the SephadexG-100 
(Shanghai Richu Bioscience Co, Ltd, China) gel chromato-
graphic column (D 2.6 cm × 40 cm, Shanghai Huxi Analysis 
Instrument Factory). Fractions were collected and monitored 
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Figure 1 The process of polysaccharide of Pleurotus eryngii extraction and purification.
for the presence of carbohydrate with a phenol–sulfuric acid 
assay.57 A single peak was observed with an ultraviolet (UV) 
absorption photometry instrument (UV2401PC, Shimadzu, 
Tokyo, Japan). The target fractions were combined and 
dialyzed against distilled water (MWCO 3500, Biosharp).39 
After lyophilization, purified PEPS was obtained.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1299
Gene delivery by cationized P. eryngii polysaccharide nanoparticles International Journal of Nanomedicine 2012:7
Preparation of CPEPS
The CPEPS was prepared by the reductive amination method 
(Figure 2) according to a previous study,32 with slight 
  modifications. The process is shown in Figure 3. The PEPS 
(0.5 g, 3.125 mmol of glucose units) was dissolved in 50 mL 
of DDW which was followed by the addition of potassium 
periodate (0.716 g, with an IO4
−/saccharide molar ratio of 1:1). 
The mixture was quickly placed in a darkroom to allow it to 
react at room temperature with vigorous magnetic stirring for 
72 hours. The resulting polyaldehyde derivative was dialyzed 
(MWCO 3500, Biosharp)39 for another 48 hours against DDW. 
After freeze-drying, oxidized PEPS was obtained.
The aldehyde content was determined according to 
  Jun-ichiro et al.58 Oxidized PEPS (0.3 g) was dissolved in 
20 mL of freshly prepared hydroxylamine hydrochloride water 
solution (0.25 M, pH 4). The resulting mixture was then gently 
stirred overnight at room temperature, followed by titration 
with standardized sodium hydroxide solution (0.1 M) till the 
end point as recorded on a digital pH meter (model PHS-3TC, 
Shanghai Tainda, Shanghai, China) was reached.
A solution of oxidized PEPS (containing 6.77 mmol 
of aldehyde groups) in 50 mL of DDW was slowly added 
(using a Sage Metering pump model 365 [Sage Metering, 
Fruiting bodies of Pleurotus
eryngii (2000 g)
H2O, at 90ºC, for 3 h (×3, 2L each time)
Residue
(discard)
Aqueous extracts
Ethanol precipitate
Lyophilized
DEAE-52 cellulose resin
Fraction without saccharide
(discard)
Fraction containing saccharide
Sephadex G-100
Fraction without
saccharide (discard)
Dialyzed, lyophilized
Purified Pleurotus eryngii
polysaccharide (PEPS)
Fraction containing
saccharide
EtOH (final concentration 75% [V/V])
Figure 2 The process of spermine grafting to the polysaccharide (dextran is used 
as an example). 
Notes:  The  reductive  amination  method  is  used  to  produce  the  cationized 
polysaccharide: the polysaccharide is first oxidized by KIO4; after the addition of 
spermine, NaBH4 is used to reduce the reactants.
PEPS (0.5 g)
Potassium periodate (0.716 g);
reacting for 72 h in a dark room
Reaction product solution
Dialyze, freeze-dry
Oxidized PEPS (0.3 g)
Dissolve in distilled water 20 mL;
add 8.46 mmol spermine
Reaction product solution
Dialyze, freeze-dry
CPEPS
Figure  3  The  process  of  cationized  Pleurotus  eryngii  polysaccharide  (CPEPS) 
preparation.
Monterey, CA]) over 2 hours to a basic solution containing a 
1.25 equimolar amount of spermine (8.46 mmol) dissolved in 
30 mL of borate buffer (0.1 M, pH 11). The mixture was then 
gently stirred at room temperature for 24 hours. Then, NaBH4 
(0.3 g) was added to the mixture to react for 48 hours and the 
process was repeated with an additional portion of NaBH4 
(0.3 g) for another 24 hours under the same conditions. The 
resulting light-yellow solution was dialyzed (MWCO 3500, 
Biosharp) for 48 hours against DDW. After freeze-drying, 
cationized PEPS (CPEPS) was obtained.
Characterization of PEPS and CPEPS
Based on the literature and the limited experimental condi-
tions in our laboratory, in this study, the average molecular 
weights of PEPS and CPEPS were analyzed with a Shimadzu 
gel permeation chromatography (GPC) system-equipped 
Shimadzu RID-10A refractive index detector (RID) 
(LC-10 AVP, Shimadzu). Analysis of the monosaccharide 
composition of PEPS was preliminarily determined by thin 
layer chromatography. After the spermine modification, 
the quantity of spermine residues that were grafted onto 
the PEPS was reflected by the amount of primary amino 
groups determined by the trinitrobenzene sulfonic acid 
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method. The quantity of total nitrogen per unit weight of 
polymer was determined with a Euro EA elemental analyzer. 
A Fourier transform infrared spectrometer (KBr) (Nicolet 
170SX, Thermo Fisher Scientific, Waltham, MA) was used 
to characterize the PEPS and CPEPS and to retrieve their 
structural information.
Preparation of plasmid DNA
The TGF-β1 was amplified in Escherichia coli host strain 
DH5α and purified by column chromatography with the 
PureYield™ Plasmid Maxiprep Start-Up Kit (Promega, 
  Madison, WI) according to the manufacturer’s protocol. 
Ampicilin was used to select for the pTGF-β1-transformed 
cells. The DNA concentration was quantified by measuring 
the UV absorbance at 260 nm with a UV spectrophotometer 
(DU 530 Life Science UV/Vis spectrophotometer; Beckman 
Coulter, Fullerton, CA).
Preparation of CPEPS-pTGF-β1 
nanoparticles
The CPEPS-pTGF-β1 nanoparticles were prepared by 
complex coacervation. A number of CPEPS-pTGF-β1 
nanoparticle samples that differed in their CPEPS/pTGF-β1 
weight ratios were prepared. The CPEPS stock solution 
(8 mg/mL) was made by dissolving 8 mg CPEPS in 1 mL 
distilled water, which was then sterilized by heating at 
80°C for 4 hours. The required solutions for the different 
CPEPS concentrations and that of the pTGF-β1 concen-
tration (400 µg/mL) were prepared with sterilized DDW. 
Meanwhile, aliquots (100 µL) of each of the CPEPS and 
pTGF-β1 working solutions were heated separately at 55°C 
for 30–45 minutes. Equal volumes of each solution were 
then quickly mixed and vortexed for 60 seconds to obtain 
the CPEPS-pTGF-β1 nanoparticles.
Analysis of gel retardation effect  
of CPEPS-pTGF-β1 nanoparticles
The CPEPS-pTGF-β1 retention effect was analyzed using 
gel electrophoresis. CPEPS-pTGF-β1 nanoparticle solutions 
(10 µL) with different weight ratios were mixed with 1 µL 
loading buffer (0.1% sodium dodecyl sulfate, 5% glycerol, 
and 0.005% bromophenol blue) and put into 1% agarose 
gel in tris-borate-ethylenediaminetetraacetic acid buffer 
  solution (pH 8.0) containing 1 µg/mL ethidium bromide. 
The diluted free pTGF-β1 solution (10 µL) was used as a 
control.   Electrophoretic evaluation of the complex was car-
ried out in tris-borate-ethylenediaminetetraacetic acid buffer 
solution at 80 V for 90 minutes. A photograph of the gel was 
taken with a UV transilluminator (Gel Doc 2000, Bio-Rad, 
Hercules, CA).
Zeta potential
The zeta potentials of the nanoparticle suspensions, which 
had different weight ratios of CPEPS to pTGF-β1 (10:1, 
20:1, and 30:1), were measured with a ZEN3600 Nano 
Series Zetasizer (Malvern Instruments, Malvern, UK). The 
zeta potentials of the free plasmid and original CPEPS were 
determined under the same conditions. This measurement 
would reflect the degree of cationization.
Determination of the nanoparticle size 
distribution
The nanoparticle size distribution was determined by a 
dynamic light scattering (DLS) technique, performed at 
25°C with a Brookhaven BI-90plus instrument (Brookhaven 
Instruments Corporation, Holtsville, NY). The measured 
scattering intensities were then analyzed by the software 
provided by Brookhaven. The determination limits of the 
size distribution generally ranged from 1 nm to 6 µm, with 
high sensitivity and reproducibility.
Transmission electron microscopy (TEM)
TEM (JEM-2100; JEOL, Tokyo, Japan) was used to detect 
the size and shape of the nanoparticles. Samples were pre-
pared by placing 1 µL nanoparticle suspension onto a   copper 
screen and allowing them to air-dry. Then, the air-dried 
samples were observed directly under TEM without the need 
to coat the samples with a conducting layer as is required for 
conventional scanning electron microscopy.
Isolation and culture of MSCs
The method of isolation and culture of MSCs was as 
described by Alhadlaq and Mao.59 The MSCs were isolated 
from 1-month-old rats by flushing the femurs and tibias with 
phosphate-buffered solution (PBS, pH 7.4). This was followed 
by the collection of 5 mL bone marrow suspensions into 
centrifuge tubes. Lymphocyte cell separation buffer (5 mL) 
was gently added into each tube along the walls of the tube. 
After centrifugation, a mist-like layer containing most of the 
MSCs had formed. The mist-like layer was then carefully 
collected into new tubes and washed twice with PBS. After 
centrifugation, the precipitate was suspended in cell culture 
medium containing DMEM, 10% FBS, low glucose (1%), 
100 U/mL penicillin, and 100 µg/mL streptomycin. The 
resulting suspension was transferred into cell culture flasks. 
The cells were incubated at 37°C in a humidified atmosphere 
of 5% CO2.
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Cytotoxicity assay
The in vitro cytotoxicity of the different CPEPS-pTGF-β1 
nanoparticles (weight ratios 10:1; 20:1; 30:1) was examined 
by MTT dye reduction assay. The second-passage MSCs were 
seeded in a 96-well plate at a cell density of 2.5 × 104 cells/well 
and incubated at 37°C for 24 hours in 100 µL of DMEM 
containing 10% FBS. After that, the medium was removed 
and replaced with a 100 µL suspension of CPEPS-pTGF-β1 
nanoparticles (pTGF-β1 200 ng/well) which had been diluted 
in a serum-free medium.   Lipofectamine 2000/pTGF-β1 and 
branched PEI (25 kDa)/pTGF-β1 were employed as control 
groups according to each manufacturer’s protocol, under the 
same conditions. This was to ensure that the optimal ratios 
for transfection were used. The concentration of pTGF-β1 in 
each group was 2 ng/µL. The same concentration of pTGF-β1 
was used in the subsequent experiments.
Cell viability was tested after the addition of the CPEPS-
pTGF-β1 complexes for 48 hours at 37°C in 5% CO2. After 
that, 10 µL of MTT solution (5 mg/mL) was added to each 
well for an additional 4-hour incubation under the same con-
ditions. The MTT-containing medium was then removed, and 
100 µL dimethyl sulfoxide was added. Dimethyl sulfoxide 
was used to dissolve the formazan crystals that were formed 
by the living cells. The absorbance was measured at 570 nm 
using a microplate reader (SpectraMax 190; Molecular 
Devices, Sunnyvale, CA). The measured absorbance was nor-
malized with the absorbance of nontreated control cells.
In vitro transfection experiments
In the transfection experiment, second-passage MSCs were 
seeded in 96-well plates at a density of 2.5 × 104 cells/well 
in 100 µL complete culture medium (DMEM, containing 
10% FBS) and incubated for a period of 24 to 48 hours to 
obtain a confluence of 80% before transfection. The medium 
was then removed and replaced with a 100 µL suspension of 
CPEPS-pTGF-β1 nanoparticles (pTGF-β1 200 ng/well) in a 
serum-free medium, which contained DMEM, 100 U/mL, and 
100 µg/mL streptomycin glutamate. In the positive control 
groups, Lipofectamine 2000/pTGF-β1 and branched PEI 
(25 kDa)/pTGF-β1 were handled rigorously according to the 
protocols provided by the manufacturers and naked pTGF-β1 
(200 ng/well) in serum-free medium was used for the negative 
control group. Four hours later, the medium was replaced with 
100 µL fresh complete medium and the cells were incubated 
for 72 hours. A rat TGF-β1 enzyme-linked immunosorbent 
assay kit (Yantai Addcare Biotech,   Shandong, China) was 
used to detect cell transfection efficiency, according to the 
protocol.
RNA isolation and reverse transcriptase 
polymerase chain reaction
Similar to the enzyme-linked immunosorbent assay test, 
second-passage MSCs were seeded in six-well plastic culture 
plates at a density of 2 × 106 cells/well in 2 mL complete cul-
ture medium (DMEM, containing 10% FBS) and incubated 
for 24–48 hours to obtain a confluence of 80%. This was 
followed by transfection as described above. After 24 hours 
of transfection, total RNA was extracted using TRIzol® 
Reagent (Invitrogen), thus following the instructions provided 
by the manufacturer. RNA concentration and purity were 
measured by a spectrophotometer (NanoDrop Technologies, 
Wilmington, DE).
Reverse transcriptase polymerase chain reaction 
analysis was carried out to determine the messenger RNA 
(mRNA) expression level of TGF-β1. The reverse tran-
scriptase reaction was conducted with 1.0 ug total RNA 
using a RevertAid™ cDNA First Strand Synthesis Kit 
(K1622; Thermo Fisher Scientific, Shenzhen, China). The 
following polymerase chain reaction (PCR) amplification 
reaction utilized the Taq polymerase and specific   primers. 
The specific sequences of the primers for PCR were 
5′-TGGTGGACCGCAACAACGCA-3′ (forward primer) 
and 5′-TGCACGGGACAGCAATGGGG-3′ (reverse 
primer) (GenBank Accession No NM 021578.2). In this 
study, glyceraldehyde 3-phosphate dehydrogenase was used 
as an internal standard. The PCR was run in an iCycler 
(Bio-Rad) using a Brilliant II SYBR® Green QPCR Master 
Mix (Stratagene, La Jolla, CA). The PCR conditions were as 
follows: 95°C for 10 minutes (for initial denaturation), fol-
lowed by 26 cycles of denaturation at 95°C for 30 seconds, 
annealing for 30 seconds at 57°C for TGF-β1 and at 58°C 
for glyceraldehyde 3-phosphate dehydrogenase, extension at 
72°C for 30 seconds. The PCR products were visualized on a 
2% (w/v) agarose gel containing 1 µg/mL ethidium bromide 
with a UV transilluminator (Gel Doc 2000, Bio-Rad).
Flow cytometry analysis
Cell cycling signals were analyzed using a GalliosTM Flow 
Cytometer (Beckman Coulter, Miami, FL). In this study, clas-
sic procedures were followed to evaluate propidium iodide 
(Beyotime Institute of Biotechnology, Shanghai, China), 
staining of DNA content. After 72 hours of transfection, cells 
were washed twice with PBS (pH 7.4) and detached from 
the wells with trypsin. The suspended cells were placed in 
sterilized centrifuge tubes and centrifuged at 1500 rpm for 
5 minutes using an Eppendorf centrifuge (Eppendorf GA, 
Hamburg, Germany), removing the supernatant. The cell 
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pellet was then washed with PBS and resuspended with 
0.5 mL of PBS (pH 7.4). The cell suspension was added into 
5 mL of 75% ethanol with precooling at −20°C (very slowly, 
drop by drop) and then fixed at 4°C overnight, followed by 
centrifuge at 1000 rpm for 5 minutes at 4°C to remove the 
ethanol. The cell pellet was washed twice with PBS + 1% 
bovine serum albumin and resuspended in 400 µL PBS + 1% 
bovine serum albumin. After that, 50 µL of 500 µg/mL pro-
pidium iodide was added into the cell suspension, followed 
by incubation at 37°C for 30 minutes before analysis by 
flow cytometer.
The cells were divided into four groups: group 1, treated 
with free pTGF-β1; group 2, treated with Lipofectamine 
2000/pTGF-β1; group 3, treated with CPEPS-pTGF-β1 
nanoparticles, and group 4, treated with medium containing 
pTGF-β1 protein.
Statistical analysis
The data were analyzed with both one-factor and two-
factor analyses of variance. Student’s t-test and the Fisher’s 
protected least significance difference post hoc test were 
used to determine the significance (significance accepted at 
P , 0.01) of the difference between selected groups with 
SPSS statistics software (v15.0; SPSS Inc, Chicago, IL). 
The data were presented as the mean ± standard error of 
the mean.
Results
Characteristics of the CPEPS
The GPC findings showed that the average molecular 
weights of the PEPS and CPEPS were 549 kDa and 333 kDa, 
respectively. The amount of primary and secondary amino 
groups derived from spermine and the percentage of cross-
linked spermine were as shown in Table 1. The findings 
showed that CPEPS was not cross-linked.
Qualitative functional group analysis of the CPEPS by 
Fourier transform infrared spectroscopy (KBr) yielded peaks 
at 3410, 1650, 1460, 1270, and 1030 cm−1 (see Figure 4). 
  Comparatively, the spectrum of the CPEPS revealed an obvious 
change at 3410 cm−1 (the presence of amine and −OH groups), 
and peaks at 1650 cm−1 (indicating the existence of −NH2),32 
1270 cm−1 (indicating the C–O group in an ester bond),39 and 
1030 cm−1 (−OH stretching) as against the spectrum of PEPS. 
This demonstrated that the amino groups were successfully 
grafted onto the backbone of the polysaccharide.
Thin layer chromatography revealed that the monosac-
charides in the PEPS mainly consisted of glucose, galactose, 
and mannose.
Gel retardation effect  
of the CPEPS-pTGF-β1 nanoparticles
Figure 5 shows the electrophoretic pattern of the tested CPEPS-
pTGF-β1 nanoparticles with different CPEPS/pTGF-β1 weight 
ratios. The nanoparticles with the lowest CPEPS/pTGF-β1 
weight ratio (1:5; well 2 of Figure 5) showed that a portion of 
the TGF-β1 plasmids had detached itself from the nanoparticles 
and migrated into the gel, as demonstrated by a faint band 
corresponding to the location of the naked TGF-β1 plasmid 
(well 1 of Figure 5). When the CPEPS/pTGF-β1 weight ratio 
was increased to 10:1 (well 3 of Figure 5), there was no sign of 
plasmid migration across the agarose gel. This indicated that 
the complexation of pTGF-β1 and CPEPS was strong enough 
to completely retard DNA migration. Accordingly, the CPEPS-
pTGF-β1 complexes with weight ratios of 10:1, 20:1, and 30:1 
were used in the subsequent transfection study.
60
4000 3500
3400
2360
1650
1460
1040
1030
581
877
1270
3410
3870
PEPS
CPEPS
3000 2500 2000 1500 1000
wave numbers (cm–1)
500
80
%
 
t
r
a
n
s
m
i
t
t
a
n
c
e
Figure 4 Fourier transform infrared spectra of polysaccharide of Pleurotus eryngii 
(PEPS) and cationized P. eryngii polysaccharide (CPEPS).
Table 1 Amino group content and cross-linking of CPEPS
Polycation Nitrogena 
(μmol/mg)
Primary aminesb 
(μmol/mg)
Sperminec 
(μmol/mg)
Secondary aminesd 
(μmol/mg)
Secondary to primary 
amine ratio
Cross-linked 
sperminee (%)
CPEPS 3.92 ± 0.23 1.24 ± 0.09 0.98 ± 0.06 2.94 ± 0.18 2.40 ± 0.30 0
Notes: aDetermined by elemental analysis (n = 3); bdetermined by the trinitrobenzene sulfonic acid method (n = 3); ccalculated from elemental analysis (total nitrogen divided 
by 4); dtheoretical secondary amine content (in case no cross-linking occurred: spermine content multiplied by 3); ecalculated for secondary to primary amine ratio $ 3. 
Abbreviation: CPEPS, cationized Pleurotus eryngii polysaccharide.
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Zeta potential
The zeta potential of the original CPEPS was +19.4 ± 0.2 mV 
(mean ± standard error for 15 runs of the same sample; 
see Figure 6). In contrast, the zeta potential of the naked 
pTGF-β1 was −42.1 ± 0.3 mV (Figure 6). At the three dif-
ferent ratios of CPEPS/pTGF-β1 (10:1, 20:1 and 30:1), the 
zeta potential changed from a negative value to a positive 
1234 567
Figure 5 Agarose gel electrophoresis of the CPEPS-pTGF-β1 nanoparticles. 
Notes:  Well  1,  free  pTGF-β1;  wells  2–7,  CPEPS-pTGF-β1  nanoparticles  with 
various weight ratios of CPEPS/pTGF-β1 (from left to right: 5:1, 10:1, 20:1, 30:1, 
60:1, and 80:1).
Abbreviations:  CPEPS,  cationized  Pleurotus  eryngii  polysaccharide;  pTGF-β1, 
plasmid encoding transforming growth factor beta-1.
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Figure 6 The zeta potentials of free pTGF-β1, CPEPS, and CPEPS combined with different amounts of pTGF-β1 to yield the following CPEPS/pTGF-β1 weight ratios: 10:1, 
20:1, and 30:1. 
Note: The values are the means ± standard error of the mean of three experiments.
Abbreviations: TGF-β1, transforming growth factor beta-1; pTGF-β1, plasmid encoding TGF-β1; CPEPS, cationized P. eryngii polysaccharide.
value and increased to +17.0 ± 0.2 mV , +17.4 ± 0.1 mV, 
and +19.2 ± 0.2 mV , respectively.
Particle size distribution and morphology
DLS demonstrated the various sizes of the nanoparticles with 
CPEPS/pTGF-β1 weight ratios of 10:1, 20:1, and 30:1. The 
size distribution of the nanoparticles with a CPEPS/pTGF-β1 
weight ratio of 20:1 ranged from 29.2 nm to 168.5 nm, with an 
average diameter of 80.8 nm (Figure 7A), whereas the aver-
age sizes of the other two nanoparticle groups were 248.3 nm 
(10:1) and 151.1 nm (30:1), respectively (Table 2).
The TEM measurement showed that the monodispersed 
nanoparticles (CPEPS/pTGF-β1 weight ratio of 20:1) had 
a spherical shape and a size distribution within a relatively 
narrow range (30–50 nm) (Figure 7B).
Cytotoxicity of the CPEPS-pTGF-β1 
nanoparticles
As shown in Figure 8, the result demonstrated that the 
CPEPS-pTGF-β1 nanoparticles yielded comparative or even 
higher cell viability than that of Lipofectamine 2000 and 
branched PEI (25 kDa), indicating that the CPEPS-pTGF-β1 
nanoparticles were safe for MSCs.
In vitro gene transfection
The TEM images of MSCs before and after transfection are 
shown in Figure 9.
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Among the three groups of different CPEPS/pTGF-β1 
weight ratios (10:1, 20:1, and 30:1), the optimal TGF-β1 
expression was recorded for a CPEPS/pTGF-β1 weight 
ratio of 20:1 (Figure 10A). Statistically, the CPEPS-
pTGF-β1 nanoparticles with a CPEPS/pTGF-β1 weight 
ratio of 20:1 revealed a significantly higher transfection 
effect than that of PEI (25 kDa) (P = 0.002, Student’s t-test) 
and   Lipofectamine 2000 (P = 0.006, Student’s t-test), the 
Table 2 The size distribution of nanoparticles with CPEPS/pTGF-
β1 weight ratios of 10:1, 20:1, and 30:1
CPEPS/pTGF-β1  
weight ratios
10:1 20:1 30:1
Particle size 
(means ± SEM, nm)
248.3 ± 7.4 80.8 ± 6.8 151.1 ± 7.2
Abbreviations:  CPEPS,  cationized  Pleurotus  eryngii  polysaccharide;  pTGF-β1, 
plasmid encoding transforming growth factor beta-1; SEM, standard error of the 
mean.
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Figure 7 Particle size distribution and morphology. (A) The particle size distribution of the CPEPS/pTGF-β1 nanoparticles with a weight ratio of 20:1; (B) transmission 
electron microscopy image of the CPEPS/pTGF-β1 nanoparticles with a  weight ratio of 20:1.
Abbreviations: CPEPS, cationized Pleurotus eryngii polysaccharide; pTGF-β1, plasmid encoding transforming growth factor beta-1.
current gold standard of commercial transfection reagents 
(Figure 10B).
mRNA expression level of TGF-β1
As shown in Figure 11, the mRNA expression level of 
TGF-β1 in CPEPS-pTGF-β1 nanoparticle-transfected 
MSCs (well 1 in Figure 11) was notably higher than that of 
MSCs transfected with free pTGF-β1 (well 2 in Figure 11) 
and also slightly higher than that of MSCs transfected with 
Lipofectamine 2000 (well 3 in Figure 11).
Flow cytometry analysis
As shown in Figure 12, the results of the flow cytometry of pro-
pidium iodide-stained cells demonstrated that the percentage 
of cells in the G1 phase for group 1 (85.20%, Figure 12A) was 
the lowest with the highest percentage being that of group 3 
(92.38%, Figure 12C). However, the percentage of cells in the 
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Figure 8 Cytotoxicity assay. From left to right: Lipofectamine™ 2000; polyethylenimine (25 kDa); free plasmid; CPEPS-pTGF-β1 nanoparticles with CPEPS/pTGF-β1 weight 
ratios of 10:1, 20:1, and 30:1. 
Note: The values are the means ± standard error of the mean of three experiments.
Abbreviations: CPEPS, cationized Pleurotus eryngii polysaccharide; PEI, polyethylenimine; pTGF-β1, plasmid encoding transforming growth factor beta-1.
S phase for group 1 (12.35%) was higher than that of the other 
three groups (group 2 [Figure 12B]: 7.55%; group 3: 7.62%, 
and group 4: 8.4% [Figure 12D]).   Interestingly, there were 
no cells in the G2 phase for group 3.
Figure 9 Transmission electron microscopy (TEM) images of MSCs before and 
after transfection. (A) TEM image of mesenchymal stem cells before transfection; 
(B–D)  TEM  images  of  mesenchymal  stem  cells  after  transfection  by  CPEPS-
pTGF-β1 nanoparticles with CPEPS/pTGF-β1 weight ratios of 10:1, 20:1, and 30:1, 
respectively.
Abbreviations:  CPEPS,  cationized  Pleurotus  eryngii  polysaccharide;  pTGF-β1, 
plasmid encoding transforming growth factor beta-1.
Discussion
In this study, PEPS was used as a gene delivery material 
for the first time. PEPS was a promising candidate for gene 
delivery after proper modification due to its advantages, 
including biocompatibility, biodegradability, nontoxicity, 
and ease of chemical modification.
Generally, the molecular weights of polymers are 
determined by GPC, which is also known as size-exclusion 
chromatography, equipped with either an RID32,60 or a light-
scattering detector.20,24 Despite the increasingly widespread 
application of DLS, GPC equipped with RID has equally 
also been used to measure the molecular weights of poly-
mers in many recent studies.32,60 Based on other studies and 
the limited experimental conditions in the laboratory, a RID 
(Shimadzu GPC system-equipped Shimadzu RID-10 A) was 
used to determine the molecular weights of PEPS and CPEPS. 
The findings revealed a drastic decease in the molecular 
weight of CPEPS (549 kDa) as compared to that of PEPS 
(333 kDa). This could possibly be due to the extensive amin-
olysis of PEPS during the conjugation reaction.38,58
In previous studies,38,58 nuclear magnetic resonance 
(NMR) was employed to further characterize the structure 
of the polysaccharide. In this work, 1H NMR spectra were 
recorded on a 400 MHz Bruker AV-400 NMR spectrometer 
(Bruker, Madison, WI) to characterize the structure of PEPS 
and CPEPS. Unfortunately, no valuable information could be 
obtained (data not shown). In some published reports58,61,62 the 
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samples had molecular weights less than 100 kDa as against 
the results of this study (.100 kDa). It is possible that the 
molecular weights of the samples were beyond the sensitivity 
of the NMR spectrometer. The exact reason is still unknown, 
and it will be explored in our future study. According to 
some researchers,39,60 it was acceptable to combine the use 
of trinitrobenzene sulfonic acid, total nitrogen determination, 
and Fourier transform infrared spectroscopy to characterize 
the CPEPS.
Spermine, an amino compound with two primary amino 
groups and two secondary amino groups on each molecule, was 
chemically grafted onto PEPS to obtain CPEPS.58 The quantity 
of the total amount of nitrogen per microgram of CPEPS indi-
cated the amount of spermine grafted on the backbone of PEPS. 
As spermine was conjugated to the polysaccharide via one of 
its primary amino groups, the conjugated primary amino group 
became a secondary amine after conjugation.38 Cross-linking 
was possible via the remaining primary amine of spermine. In 
this study, no cross-linking was observed (Table 1), indicating 
good control of the reaction conditions. Significantly, a low 
degree of cross-linking was desirable in this application.
The study investigated the monosaccharide content 
of the PEPS via preliminary thin layer chromatography 
analysis and found that D-glucose was the major monosac-
charide component; the other components were galactose 
and   mannose. The results were in agreement with previous 
studies.50 It was speculated that because D-glucose was the 
major monosaccharide in PEPS, the monomer was more 
likely to be grafted with spermine. It was also likely that the 
spermine might be linked to the other monosaccharide com-
ponents. In a related study, various polysaccharides (pullulan, 
dextran, and mannan) with different cationization degrees 
were used to transfect MSCs in order to examine the factors 
affecting transfection.63 The findings showed that the gene 
expression level was closely related to the type of cationized 
  polysaccharide. The exact composition of PEPS monosac-
charides, which are the major contributors of cationization, 
will be addressed in future works.
Gel electrophoresis showed that the cationized polysac-
charide could successfully incorporate TGF-β1 plasmid. The 
complexation of CPEPS and TGF-β1 plasmid was CPEPS-
content dependent, with a greater CPEPS/pTGF-β1 weight 
ratio resulting in better plasmid incorporation.
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Figure 10 TGF-β1 protein released into the medium from mesenchymal stem cells 
72 hours after treatment with CPEPS-pTGF-β1 nanoparticles. (A) TGF-β1 protein 
concentrations  in  the  medium  with  various  weight  ratios  of  CPEPS  to  pTGF-β1: 
10:1 (first bar), 20:1 (second bar), and 30:1 (third bar), as well as in free plasmid 
DNA  (fourth  bar).  (B)  A  comparison  of  TGF-β1  expression  levels:  free  plasmid 
DNA (first bar); Lipofectamine™ 2000 (second bar); polyethylenimine (25 kDa, third 
bar); and CPEPS-pTGF-β1 nanoparticles with a CPEPS/pTGF-β1 weight ratio of 20:1   
(fourth bar).
Note: The values are the means ± standard error of the mean of three experiments.
Abbreviations:  TGF-β1,  transforming  growth  factor  beta-1;  pTGF-β1,  plasmid 
encoding  TGF-β1;  CPEPS,  cationized  Pleurotus  eryngii  polysaccharide;  PEI, 
polyethylenimine.
Figure 11 Messenger RNA expression of TGF-β1  in  mesenchymal  stem  cells 
(MSCs).
Notes: Well 1, MSCs transfected with free pTGF-β1; well 2, MSCs transfected 
with  Lipofectamine™  2000/pTGF-β1;  well  3,  MSCs  transfected  with  CPEPS-
pTGF-β1 nanoparticles.
Abbreviations: TGF-β1, transforming growth factor beta-1; CPEPS, cationized 
Pleurotus  eryngii  polysaccharide;  pTGF-β1,  plasmid  encoding  TGF-β1;  GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase.
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It is well known that DNA charge reversal is one 
of the basic requirements for the transfection of cells. 
Interestingly, the zeta potentials of the three different CPEPS-
pTGF-β1 nanoparticles were almost the same as that of the 
original polysaccharide (+19.4 ± 0.2 mV) and statistically 
insignificant (see Figure 6.) This implies that the negatively 
charged plasmids were successfully combined with the posi-
tively charged polysaccharide to form nanoparticles of more 
positive charges on its outer surface. Therefore, the value of 
the positive charges on the surface of the nanoparticles will 
be comparable to that of the original CPEPS. This point will 
be further investigated in future studies.
The particle size values provided by TEM (30–50 nm, 
Figure 7B) and DLS (29.2∼168.5 nm) were quite different 
(Table 2 and Figure 7A). A possible reason could be that 
the DLS and TEM had various determination conditions: 
samples measured by DLS were in suspended form, whereas 
dried particles were observed under TEM. In summary, the 
CPEPS-pTGF-β1 complex had a nanoscaled particle size. 
  Interestingly, these findings showed that the average   particle 
size of the formulated nanoparticles (CPEPS/pTGF-β1 
weight ratio of 20:1) was 80.8 nm in diameter, which was 
much smaller than the sizes reported in previous studies 
(cationized gelatin15 and chitosan25 nanoparticles with an 
average size of approximately 172 nm in diameter and 250 nm 
in diameter were produced, respectively). However, the aver-
age size of the nanoparticles with a CPEPS/pTGF-β1 weight 
ratio of 30:1 was 151.1 nm which is obviously larger than that 
of the 20:1 nanoparticles. This large particle size suggested 
that excess cationic polysaccharide might acquire a greater 
positive zeta potential, but it could also cause redundant 
CPEPS coacervation on the particle surface resulting in a par-
ticle size increase. This is unfavorable for cellular uptake.
Low cytotoxicity is one of the basic requirements for a 
safe and effective gene carrier. The outcome of the MTT test 
showed that the CPEPS-pTGF-β1 nanoparticles exhibited 
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Figure 12 Flow cytometry of propidium iodide-stained mesenchymal stem cells (MSCs). (A) MSCs treated with plasmid TGF-β1; (B) MSCs treated with Lipofectamine™ 
2000/pTGF-β1; (C) MSCs treated with CPEPS-pTGF-β1 nanoparticles; (D) MSCs treated with medium containing pTGF-β1 protein.
Abbreviations: TGF-β1, transforming growth factor beta-1; pTGF-β1, plasmid encoding TGF-β1; CPEPS, cationized Pleurotus eryngii polysaccharide.
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an exceptional safety profile (Figure 8). It is likely that the 
intracellular degradability of the polymer was responsible for 
the low cytotoxicity of CPEPS.49 Inside the cells, the CPEPS 
could be degraded to different kinds of monosaccharides 
and oligoamines, which were easily metabolized, hence 
nontoxic.64 Essentially, the CPEPS-pTGF-β1 nanoparticles 
prepared in this study were safe for MSCs.
Cell transfection efficiency is the key index in evaluating 
the properties of nonviral gene carriers. The results of the 
CPEPS-pTGF-β1 nanoparticles with a weight ratio of 20:1 
(80.8 nm on average) showed the highest transfection effi-
ciency (Figure 10A). This means that the smaller size of the 
nanoparticles facilitated the movement of the particles through 
membranes. In addition, when the CPEPS/pTGF-β1 weight 
ratio was lower than 20:1, it could possibly lead to an incom-
plete encapsulation of the negatively charged naked pTGF-β1, 
resulting in a relatively large particle size (248.3 nm) that 
probably hindered the process of cellular uptake. This assertion 
was also supported by the gel retardation assay (Figure 5). It 
was observed that there was less tendency for the plasmid to 
migrate as the CPEPS/pTGF-β1 weight ratio increased. The 
free plasmid DNA showed the greatest migration towards the 
positive pole. This implies that the complex with a weight ratio 
of 10:1 had an inadequate amount of cationic polysaccharide. 
In the case of the nanoparticles with a CPEPS/pTGF-β1 
weight ratio greater than 20:1, the reduced TGF-β1 expression 
could possibly be due to a larger particle size (151.1 nm), as 
well as to the strong bond of attraction between the CPEPS 
and pTGF-β1. This would have prevented the release of 
pTGF-β1 from the nanoparticles in a timely and complete 
manner once the nanoparticles entered the cells. Additionally, 
a high CPEPS/pTGF-β1 weight ratio might lead to the state 
of free CPEPS that could competitively inhibit the interaction 
between CPEPS-pTGF-β1 nanoparticles and cell membrane.39 
Further investigations would be needed to provide a deeper 
understanding of the MSC transfection mechanisms with 
respect to the CPEPS/pTGF-β1 weight ratio.
Interestingly, the CPEPS-pTGF-β1 nanoparticles (weight 
ratio of 20:1) showed a significantly enhanced transfection 
effect as compared to those of PEI (25 kDa), (P = 0.002, 
  Student’s t-test) and Lipofectamine 2000 (P = 0.006, 
Student’s t-test). This was possible because CPEPS could 
condense the TGF-β1 plasmid to a small size (80.8 nm on 
average), which facilitated the process of cellular uptake. 
At the same time, the positive charge on the surface of the 
nanoparticle (+17.4 ± 0.1 mV) promoted the interaction with 
the negatively charged cell membranes. It is a well-known 
fact that polysaccharides can readily be transported to cells by 
known biological processes, which might greatly contribute 
to the success of the transfection.38
In the study, long-term (72-hour) expression of TGF-β1 
by MSCs was also investigated. In a related study,64 immu-
nofluorescence staining was conducted to check if the stem 
cells had differentiated after transfection. The findings of 
that study showed that the transfection was transient. In 
this study, the results supported that, and after transfection 
stem cells still maintained mesenchymal lineage properties 
(data not shown). This could also be supported by the TEM 
images of MSCs before and after transfection, which exhib-
ited no obvious morphological changes after transfection. 
  Longer-term (more than 72-hour) transfection investigation 
will be addressed in future works.
Reverse transcriptase polymerase chain reaction was car-
ried out to reflect the transfection effect of CPEPS-pTGF-β1 
nanoparticles from the mRNA expression level of TGF-β1, 
and the result was in agreement with that revealed by enzyme-
linked immunosorbent assay, indicating the high transfection 
effect of CPEPS-pTGF-β1 nanoparticles and their superiority 
over Lipofectamine 2000.
It is well known that the S phase is the cell cycle phase 
for DNA synthesis which prepares the cells for mitosis, and 
the G1 phase is the cell stage after mitosis to the beginning 
of the S phase. So the cells moving from the S to the G1 
phase indicated a tendency of differentiation. Flow cytometry 
analysis revealed that cells transfected with CPEPS-pTGF-β1 
nanoparticles had low proliferation but showed a tendency 
of differentiation. This could possibly be due to the effect 
of TGF-β1 on MSCs, because TGF-β1 has the ability to 
induce chondrogenesis of MSCs.65 Further investigation of 
this aspect will be addressed in future studies.
Conclusion
In this study, a polysaccharide isolated from the edible mush-
room P . eryngii was chemically modified with spermine for 
the first time to obtain CPEPS, out of which CPEPS-pTGF-β1 
nanoparticles were then prepared. Gel retardation assay showed 
that CPEPS-pTGF-β1 nanoparticles possessed the ability to 
prevent the plasmid DNA from migrating when the CPEPS/
pTGF-β1 weight ratio increased to 10:1.   Varying the CPEPS 
to TGF-β1 plasmid weight ratio affected the TGF-β1 expres-
sion significantly, with the highest transfection efficiency 
noted at the CPEPS/pTGF-β1 weight ratio of 20:1. In addi-
tion, the CPEPS-pTGF-β1 nanoparticles (weight ratio of 
20:1) showed significantly enhanced transfection efficiency 
compared with that of Lipofectamine 2000.   Cytotoxicity 
assay revealed that the CPEPS/pTGF-β1 nanoparticles were 
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less toxic than both PEI (25 kDa) and Lipofectamine 2000. 
Furthermore, the mRNA expression level of TGF-β1 in MSCs 
transfected by CPEPS-pTGF-β1 nanoparticles was signifi-
cantly higher than that of free plasmid DNA-  transfected MSCs 
and slightly elevated compared with that of Lipofectamine™ 
2000-transfected MSCs. Flow cytometry analysis revealed 
that 92.38% of MSCs were arrested in the G1 phase after 
transfection with CPEPS-pTGF-β1 nanoparticles, indicating 
a tendency of differentiation. All of these findings support 
the fact that the CPEPS-pTGF-β1 nanoparticles could be 
developed into a promising gene delivery system in the near 
future.
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